Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men. [electronic resource]
Producer: 20060918Description: 2882-7 p. digitalISSN:- 0021-972X
- Aged
- Aged, 80 and over
- Alendronate -- administration & dosage
- Bone Density Conservation Agents -- administration & dosage
- Bone Remodeling -- drug effects
- Collagen Type I -- blood
- Humans
- Male
- Middle Aged
- Osteocalcin -- blood
- Osteoporosis -- drug therapy
- Peptide Fragments -- blood
- Peptides -- blood
- Procollagen -- blood
- Teriparatide -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.